World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
38867
World Ranking
9563
National Ranking
4928

Research.com Recognitions

  • 2014 - Fellow of the American Association for the Advancement of Science (AAAS)
  • 1997 - Member of the National Academy of Medicine (NAM)
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

John Mendelsohn was affiliated with The University of Texas at Austin in the United States. Their research primarily focused on environmental science, with an emphasis on ecology and related subfields.

The main fields of study encompassed:

  • Environmental Science

Their subfields of research included:

  • Ecology
  • Nature and Landscape Conservation
  • Ecological Modeling
  • Management, Monitoring, Policy and Law
  • Ecology, Evolution, Behavior and Systematics

The scientist's work covered several topics, notably:

  • Wildlife Ecology and Conservation
  • Ecology and Vegetation Dynamics Studies
  • Species Distribution and Climate Change
  • Avian ecology and behavior
  • Rangeland Management and Livestock Ecology
  • Animal Behavior and Reproduction
  • Aquatic Ecosystems and Biodiversity

Key publications that reflect the scope of their research included:

  • "Africa's drylands in a changing world: Challenges for wildlife conservation under climate and land-use changes in the Greater Etosha Landscape," 2022, published in Global Ecology and Conservation
  • "Understanding continent-wide variation in vulture ranging behavior to assess feasibility of Vulture Safe Zones in Africa: Challenges and possibilities," 2022, published in Biological Conservation
  • "A utilization distribution for the global population of Cape Vultures (Gypscoprotheres) to guide wind energy development," 2023, published in Ecological Applications
  • "Quantifying spatial ignorance in the effort to collect terrestrial fauna in Namibia, Africa," 2023, published in Ecological Indicators
  • "Double-brooding in Southern Yellow-billed Hornbills Tockus leucomelas," 2021, published in Ostrich

The frequent co-authors who collaborated with Mendelsohn included:

  • Monique MacKenzie
  • Nina Farwig
  • Ryno Kemp
  • Sascha Rösner
  • Dana G. Schabo

Their research was published in venues such as:

  • Global Ecology and Conservation
  • Biological Conservation
  • Ecological Applications
  • Ecological Indicators
  • Ostrich

Mendelsohn was a recipient of several distinctions including:

  • Fellow of the American Association for the Advancement of Science (AAAS), 2014
  • Member of the National Academy of Medicine (NAM), 1997
  • Member of the Association of American Physicians

Best Publications

  • Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.

    J. Baselga;Debasish Tripathy;J. Mendelsohn;S. Baughman

  • The EGF receptor family as targets for cancer therapy.

    John Mendelsohn;Jose Baselga

  • Status of Epidermal Growth Factor Receptor Antagonists in the Biology and Treatment of Cancer

    John Mendelsohn;Jose Baselga

  • Recombinant Humanized anti-HER2 Antibody (Herceptin) Enhances the Antitumor Activity of Paclitaxel and Doxorubicin Against HER2/neu Overexpressing Human Breast Cancer Xenografts

    Jose Baselga;Larry Norton;Joan Albanell;Young Mee Kim

  • Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model.

    Neil I. Goldstein;Marie Prewett;Kazys Zuklys;Patricia Rockwell

  • The Molecular Basis of Cancer

    John Mendelsohn;Peter M. Howley;Mark A. Israel;Joe W. Gray

  • Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin

    Jose Baselga;D. Pfister;M. R. Cooper;R. Cohen

  • Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody.

    T. Kawamoto;J. D. Sato;A. Le;J. Polikoff

  • Epidermal Growth Factor Receptor Targeting in Cancer

    John Mendelsohn;Jose Baselga

  • Growth Inhibition of Human Tumor Cells in Athymic Mice by Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies

    H Masui;T Kawamoto;J D Sato;B Wolf

  • Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors.

    J. D. Sato;T. Kawamoto;A. D. Le;J. Mendelsohn

  • Antitumor Effect of Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies plus cis-Diamminedichloroplatinum on Well Established A431 Cell Xenografts

    Zhen Fan;Jose Baselga;Hideo Masui;John Mendelsohn

  • In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody.

    Luka Milas;Kathy Mason;Nancy Hunter;Sven Petersen

  • HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells

    Christiane Knuefermann;Yang Lu;Bolin Liu;Weidong Jin

  • Targeting the epidermal growth factor receptor for cancer therapy

    John Mendelsohn

  • Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies.

    Jose Baselga;Larry Norton;Hideo Masui;Atanasio Pandiella

  • Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin.

    Xipu Wu;Zhen Fan;Hideo Masui;Neal Rosen

  • Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials

    Maria Schwaederle;Melissa Zhao;J. Jack Lee;Alexander M. Eggermont

  • Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial.

    Jordi Rodon;Jean Charles Soria;Raanan Berger;Wilson H. Miller

  • Antitumor Effect of Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies plus cis-Diamminedichloroplatinum on Well Established

    Zhen Fan;Jose Baselga;Hideo Masui;John Mendelsohn

Frequent Co-Authors

Gordon B. Mills
Gordon B. Mills Oregon Health & Science University
José Baselga
José Baselga Memorial Sloan Kettering Cancer Center
Funda Meric-Bernstam
Funda Meric-Bernstam The University of Texas MD Anderson Cancer Center
Giampaolo Tortora
Giampaolo Tortora University of Verona
Peter M. Howley
Peter M. Howley Harvard Medical School
Rakesh Kumar
Rakesh Kumar The University of Texas MD Anderson Cancer Center
Mahitosh Mandal
Mahitosh Mandal Indian Institute of Technology Kharagpur
Craig B. Thompson
Craig B. Thompson Memorial Sloan Kettering Cancer Center
Razelle Kurzrock
Razelle Kurzrock Medical College of Wisconsin
Joe W. Gray
Joe W. Gray Oregon Health & Science University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in medicine doesn’t always mean pursuing a traditional MD. The healthcare sector offers diverse online degree options—many designed to fit around busy lifestyles and financial needs.

One popular entry point is medical billing and coding financial aid programs, which make it easier to get started in healthcare administration with reduced tuition costs. For those seeking clinical roles, there are nursing school no entrance exam options, removing some common barriers and expediting entry into nursing education.

If you’re interested in leadership, healthcare administration programs online offer the flexibility to advance your career while balancing work and family commitments. Additionally, registered nurses can accelerate their learning through adn to np programs online, helping them move into advanced practice roles much faster than with traditional degree paths.

With so many accredited online degrees and alternative pathways, aspiring medical professionals have more opportunities than ever to build a rewarding career in healthcare.

Best Scientists Citing John Mendelsohn